Feasibility Study of Anti-inflammatory Cytokines in Whole Blood in Osteoarthritis Patients
NCT ID: NCT01050894
Last Updated: 2017-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
105 participants
OBSERVATIONAL
2010-05-31
2012-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Phase II Study of CG100649 for Primary Osteoarthritis in Male Subjects
NCT00530452
Osteoarthritis Initiative (OAI): A Knee Health Study
NCT00080171
Effect of Anti-inflammatory (ITIS) Diet in Knee Osteoarthritis
NCT05559463
Study of Nonsteroidal Anti-inflammatory Drugs in People With Painful Knee Osteoarthritis
NCT05430230
A Study to Evaluate the Safety and Efficacy of 2ccPA in Patients With Symptomatic Knee Osteoarthritis
NCT05807529
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
osteoarthritis patients
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* signed informed consent
Exclusion Criteria
* \< 18 years of age
* blood clotting disorder or active hematologic cancer
* undergoing chemotherapy
* history of rheumatoid arthritis
* septic joint or fracture
* active infection or history of chronic infection
* use of cytokine blocking drugs with the last 6 months
* intra-articular steroid or hyaluronic acid (HA) injection within last 6 months
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zimmer Biomet
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
OrthoIndy
Indianapolis, Indiana, United States
Orthopaedic Surgery, Kentucky Clinic
Lexington, Kentucky, United States
Ohio State University Sports Medicine Center
Columbus, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APS-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.